Yang Ling

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors

John L. Marshall, Huanwen Chen, Dongxiao Yang et al. · Annals of Oncology · 2004 · 72 citations · Full text

Advanced Breast Cancer, Breast Oncology, Medicine +10

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

D. Ross Camidge, Eamon M. Berge, Robert C. Doebele et al. · Journal of Thoracic Oncology · 2014 · 51 citations · Full text

Management of Small Cell Carcinoma of Esophagus in China

Xujing Lu, Judong Luo, Yang Ling et al. · Journal of Gastrointestinal Surgery · 2013 · 45 citations · Full text

Upregulation of <scp>Y</scp>ing <scp>Y</scp>ang 1 (<scp>YY</scp>1) suppresses esophageal squamous cell carcinoma development through heme oxygenase‐1

Judong Luo, Xifa Zhou, Xin Ge et al. · Cancer Science · 2013 · 44 citations · Full text

Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy

Yongping Liu, Yang Ling, Qiufeng Qi et al. · Molecular and Clinical Oncology · 2017 · 38 citations · Full text

Tumor Biology, Prognostic Biomarkers, Ctc Counts +15